Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Applications are invited for the 2018 Jill and Herbert Hunt Travelling Scholarship to support travel abroad for clinical study or research from graduates of the Oxford University Medical School.

© Shutterstock

Image courtesy of Shutterstock

The scholarship is of the value of about £4,000 and may be held with another award. This scholarship is offered in every second year.

Eligibility to apply:

Candidates must either hold the Degrees of Bachelor of Medicine and Bachelor of Surgery of the University of Oxford or have passed the First Examination for the Degree of Bachelor of Medicine of the University and hold a medical degree of another British university qualifying him or her to practise medicine. Current medical students are not eligible to apply; an award can only be made to an Oxford medical graduate who fulfils the above criteria.

Candidates are required to submit:

  • A letter of application outlining why they wish to apply for the scholarship and details of their proposed period of study, including an undertaking that, if elected, they will travel abroad for a period of at least one month for the purpose of clinical study or research in medicine
  • An estimate of the costs of the proposed period of clinical study or research
  • A statement of their academic record/CV
  • Two testimonals in support of the candidate/application.

The scholar will be required to complete his or her period of travel within twelve months from the date of election, and within a reasonable period thereafter to submit to the Secretary of the Medical School for the approval of the electors a detailed report of his or her tenure of the scholarship. Payment of nine-tenths of the scholarship will be made shortly before the period of travel, and the remaining one-tenth following the approval of the report. The election will be made on 8 April 2018.

Applications should be sent to Laura Morgan, Medical School Office, Academic Centre, Level 2, John Radcliffe Hospital, Headington, Oxford, OX3 9DU. E-mail: laura.morgan@medsci.ox.ac.uk.

The closing date for applications will be 16 February 2018.

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.